Skip to main content

stock

AKTX · Akari Therapeutics Plc

What Akari Therapeutics Plc reports to the SEC, read from its filings.

Open in the app

Price

The live AKTX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on AKTX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
155,758,529,533 as of 2026-08-13 (XBRL frame )

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-166.5%
ROA
-80.2%

Health

Current ratio
0.6x
Debt/equity
—

Deep value

NCAV
-$11.71M
NCAV per share
-$0.00
Price/NCAV
Locked
NNWC
-$12.34M
NNWC per share
-$0.00
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$4.60M-$4.81M
10-Q filed 2026-08-13
2026-03-31——Gross profit: unreported by this company.-$15.76M-$14.46M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——Gross profit: unreported by this company.-$3.23M-$5.30M
DEF 14A filed 2026-06-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——Gross profit: unreported by this company.-$7.40M-$6.40M
10-Q filed 2025-11-13
2025-06-30——Gross profit: unreported by this company.-$3.12M-$1.90M
10-Q filed 2026-08-13
2025-03-31——Gross profit: unreported by this company.-$3.52M-$3.71M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——Gross profit: unreported by this company.-$5.28M-$3.78M
DEF 14A filed 2026-06-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30——Gross profit: unreported by this company.-$2.93M-$2.90M
10-Q filed 2025-11-13
Assets
$38.62M
Equity
$18.59M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$17.27M-$17.30M—
2024-12-31—-$21.64M-$19.80M—
2023-12-31$367,877-$16.81M-$10.01M-$16.43M
2022-12-31$607,681-$11.85M-$13.09M-$7.63M
2021-12-31—-$17.21M-$17.42M—
2020-12-31—-$17.98M-$17.08M—
2019-12-31—-$16.96M-$16.85M-$12.92M
2018-12-31—-$20.79M-$20.50M-$22.77M
2017-12-31—-$37.78M-$35.40M-$31.64M
2016-12-31—-$27.25M-$18.14M-$24.68M

Company filings

since Fri Jul 10 · 3 offering filings in 12 months

events

  • Executive or director change

    Executive or director change
    Oct 18-K
  • Results

    Results
    Aug 138-K
  • Shareholder vote results

    Shareholder vote results
    Jul 28-K
  • Material agreement

    Material agreement
    Jun 268-K
  • Material agreement, Unregistered share sale

    Material agreementUnregistered share sale
    May 228-K
  • Shareholder rights changed, Regulation FD disclosure

    Shareholder rights changedRegulation FD disclosure
    Mar 178-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named AKTX, and the market events around them.

Sign in to see this

Board

The AKTX board could not be loaded.

Retry the AKTX board

nakagai

Signals on AKTX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the AKTX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Akari Therapeutics Plc (AKTX): SEC filings, financials and insider trades · Nakagai